Checking AVBP unusual options activity helps you spot when traders are making outsized bets on ArriVent BioPharma Inc before the broader market catches on. ArriVent BioPharma Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor AVBP unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching AVBP unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking AVBP unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and AVBP unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc.
The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
Catalysts rarely arrive without a footprint, and AVBP unusual options activity is often where that footprint shows up first. Our scanner tracks ArriVent BioPharma Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at AVBP unusual options volume on the call side or chasing put sweeps, ArriVent BioPharma Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
